261901-57-9,
SB 269970 hydrochloride,
SB-269970 hydrochloride,
SB269970 HCl,
(R)-3-((2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidin-1-yl)sulfonyl)phenol hydrochloride,
SB-269970 (hydrochloride),
SB 269970A,
MFCD03788020,
(R)-3-[2-[2-(4-Methylpiperidin-1-yl)ethyl]pyrrolidine-1-sulfonyl]phenol hydrochloride,
SR-01000076135,
EU-0101059,
sb-269970-hcl,
C18H29ClN2O3S,
MLS002153418,
SB 269970 hcl,
SCHEMBL2719586,
CHEMBL1256844,
CTK8B9470,
KS-00000XMZ,
SB-269970 HCl,
BCP14529,
Tox21_501059,
2275AB,
ABP000324,
ANW-62575,
BN0629,
HY-15370A,
s2849,
AKOS016004346,
CCG-222363,
CS-1644,
LP01059,
SB-269970A,
NCGC00094341-01,
NCGC00261744-01,
Phenol, 3-[[(2R)-2-[2-(4-methyl-1-piperidinyl)ethyl]-1-pyrrolidinyl]sulfonyl]-, hydrochloride (1:1),
SMR001230794,
AX8233428,
RT-015655,
SW220129-1,
S 7389,
J-013020,
J-016312,
SR-01000076135-2,
SR-01000076135-3,
SB-269970 hydrochloride, powder, >=98% (HPLC),
(R)-3-((2-(2-(4-METHYLPIPERIDIN-1-YL)ETHYL)PYRROLIDIN-1-YL)SULFONYL)PHENOL HCL,
(R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidin-1-ylsulfonyl)phenol hydrochloride,
[R]-3-[2-(2-[4-Methyl-piperidin-1-yl]ethyl)pyrrolidine-1-sulfonyl]phenol hydrochloride,
(2r)-1-[(3-hydroxyphenyl)sulfonyl]-2-[2-(4-methyl-1-piperidinyl)ethyl] pyrrolidine hydrochloride,
(2R)-1-[(3-Hydroxyphenyl)sulfonyl]-2-[2-(4-methyl-1-piperidinyl)ethyl]pyrrolidine hydrochloride,
D0BG5H,
SB-269970,
CID11957684,
SB 269970-A,
B2254,
201038-74-6,
65057-90-1,